DIM deterred EMT in prostate cancer cells by blocking AR signaling and the expression of prostate-specific antigen (PSA), an AR-target gene, resulting in the reduction of the expression of EMT markers, ZEB1, N-cadherin and fibronectin [140]. Here, KLK3 is linked to prostate carcinoma.